Funding for the innovative center should boost the technological economy, facilitate scientific collaboration and foster entrepreneurship in Puerto Rico. #NewsismyBusiness
CytoImmune Therapeutics, Inc. and Biosimilar Solutions, LLC will establish operations in Puerto Rico to develop their biotechnology products. Both initiatives represent a combined investment of some $228 million and the creation of 400 jobs, economic ...
INDUNIV, an organization that for 38 years has been the voice of the bioscience industry in Puerto Rico, will represent the island at the BIO International Convention,” in Boston from June 4-7.